{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Turing Pharmaceuticals founder Martin Shkreli plans to sharply increase price of drug treating Chagas disease, parasitic infection that can lead to potentially lethal heart problems; company will seek Food and Drug Administration approval for drug already in use in some countries and try to cash in with federal voucher intended to encourage research.", "type_of_material": "News", "word_count": "1362", "lead_paragraph": "Critics say that Turing, the pharmaceutical led by Mr. Shkreli, is exploiting a program that awards vouchers that can be sold at huge profits while pricing drugs out of patients\u2019 reach.", "pub_date": "2015-12-12T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Martin Shkreli\u2019s Latest Plan to Sharply Raise Drug Price Prompts Outcry", "print_headline": "Turing Moves to Next Drug "}, "snippet": "Critics say that Turing, the pharmaceutical led by Mr. Shkreli, is exploiting a program that awards vouchers that can be sold at huge profits while pricing drugs out of patients\u2019 reach.", "multimedia": [{"height": 126, "url": "images/2015/12/12/business/12chagas-web1/12chagas-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/12/12/business/12chagas-web1/12chagas-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/12/12/business/12chagas-web1/12chagas-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/12/12/business/12chagas-web1/12chagas-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/12/12/business/12chagas-web1/12chagas-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/12/12/business/12chagas-web1/12chagas-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/12/business/martin-shkrelis-latest-plan-to-sharply-raise-drug-price-prompts-outcry.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Chagas Disease", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "5", "is_major": "N", "value": "Centers for Disease Control and Prevention", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Prices (Fares, Fees and Rates)", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Drugs for Neglected Diseases Initiative", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "9", "is_major": "N", "value": "Latin America", "name": "glocations"}], "blog": [], "_id": "566b65ad38f0d804c3f4bcbb", "source": "The New York Times"}